Imagen molecular en amiloidosis cardíaca

Luisa Talledo Paredes; Francisco Pasapera; Delia Guerrero Ramirez; Pierre Araujo Puicón

doi:10.47487/apcyccv.v2i2.136

Authors

Luisa Talledo Paredes Servicio de ayuda al diagnóstico y tratamiento, Instituto Nacional Cardiovascular INCOR, Essalud, Lima, Perú
Francisco Pasapera Medical technologist. Instituto Nacional Cardiovascular INCOR- Lima, Peru
Delia Guerrero Ramirez Medical technologist. Instituto Nacional Cardiovascular INCOR- Lima, Peru
Pierre Araujo Puicón Medical technologist. Instituto Nacional Cardiovascular INCOR- Lima, Peru

DOI:

https://doi.org/10.47487/apcyccv.v2i2.136

Keywords:

Amyloidosis, Radionuclide imaging

Abstract

A review is made of the original article by Muñoz-Moreno J. on cardiac amyloidosis in which pyrophosphate scintigraphy images are described. International variations are specified as well as the different protocols performed at the National Cardiovascular Institute and the status of the radiopharmaceuticals used.

Downloads

Download data is not yet available.

References

Muñoz Moreno JM, Añorga Ocmin J, Espinola García S, et al. Amiloidosis cardíaca: experiencia en un instituto cardiovascular de referencia nacional. APCyCCV [Internet]. 9 de julio de 2020 [citado11 de mayo de 2021];1(2):95 -04. Disponible en: https://apcyccv.org.pe/index.php/apccc/article/view/40. doi: https://doi.org/10.47487/apcyccv.v1i2.40

Perugini E, Guidalotti P, Salvi F, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84. doi:10.1016/j.jacc.2005.05.073.

Bokhari S, Casta o A, Pozniakoff B, et al. 99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis from the Transthyretin-Related Familial and Senile Cardiac Amyloidosis. Circulation: Cardiovascular Imaging 2013; 6: 195-201. https://doi.org/10.1161/CIRCIMAGING.112.000132

Dorbala S, Ando Y, Bokhari S, et al. Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-evidence Base and Standardized Methods of Imaging. J Nucl Cardiol. 2019; 26(6): 2065-123. doi: 10.1007/s12350-019-01760-6

González-López E, López-Sainz A, Garcia-Pavia P. Diagnóstico y tratamiento de la amiloidosis cardíaca por transtiretina. Progreso y esperanza. Rev Esp Cardiol. 2017; 70(11): 991–1004. doi: 10.1016/j.recesp.2017.05.018

Singh V, Falk R, Di Carli M, et al. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J. Nucl. Cardiol. 26, 158–73(2019). https://doi.org/10.1007/s12350-018-01552-4